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Abstract Rat adrenocortical cells take up high density lipo- 
protein cholesterol for use as steroidogenic substrate. To better 
understand this unique uptake process, we have first charac- 
terized HDL binding. Infusion of human ‘251-labeled HDL 
into rats pretreated with 4-APP demonstrated that the adrenal 
and ovary accumulate HDL in a saturable fashion in vivo. 
Subsequent studies using isolated rat adrenocortical cells dem- 
onstrated that cellular uptake of HDL is comprised of two 
events. One event is characterized by reversible membrane 
binding and is complete by 60 min = 20 min). The 
second event is marked by irreversible apoprotein accumulation 
which continues for at least 3 hr. Reversibly bound material 
exhibits the same apoprotein distribution as unincubated HDL. 
Irreversible accumulation could not be attributed to intemal- 
ization or lysosomal accumulation inasmuch as it also occurred 
with partially purified plasma membranes and was not enhanced 
by addition of chloroquine. Reversible binding of human 
HDLS exhibited a saturable dependence on concentration (rC, 
= 27 pg protein/ml; N = 3.0 X lo6 sites/cell) similar to that 
previously reported for rat liver, ovary, and testis. Cell accu- 
mulation of HDL decreased by over 80% at 4°C compared to 
37”C, did not require calcium, and was not diminished by 
prior cell treatment with trypsin or pr0nase.M These results 
indicate that rat adrenocortical cells possess plasma membrane 
recognition sites for HDL with different properties than those 
of the LDL receptor. Moreover, adrenal accumulation of HDL 
apoproteins does not lead to secondary lysosome formation.- 
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Circulating serum lipoproteins provide cholesterol 
substrate for steroidogenesis in the adrenal and ovaries 
of most species including man and the rat (1 -3). In the 
fasting state, two major lipoprotein classes, high density 
(HDL) and low density (LDL) lipoproteins, carry greater 
than 90% of circulating cholesterol. The relative amount 
of each lipoprotein class varies among species, with HDL 
predominant in rat (4) and LDL predominant in man 
(5 ) .  The biological activity of lipoprotein particles is 
determined by their constituent apoproteins and lipids 
rather than by their density (6, 7). 
One mechanism by which adrenal cells have been 
shown to accumulate lipoprotein cholesterol is receptor- 
mediated endocytosis (3). This process, which is identical 
to that described by Brown and Goldstein in cultured 
human fibroblasts (€9, is initiated by binding to the 
“LDL receptor.” The properties of the “LDL receptor” 
have been well characterized (9-12). Cultured mouse 
Y-1 adrenal tumor cells (13), long-term cultures of 
bovine adrenal cortical cells ( 14, 15), human fetal adrenal 
cells (1 6), and rabbit adrenocortical cells (1 7) have been 
shown to accumulate LDL but not HDL cholesterol by 
“LDL receptor”-mediated endocytosis. LDL cholesterol 
accumulated in this fashion provides substrate for en- 
hanced steroidogenesis. 
Considerable evidence now indicates that the adrenal 
glands (18-22), testes (23), and ovaries of rats (24, 25) 
and mice (26) and possibly bovine ovaries as well (27) 
possess a distinct mechanism for accumulating HDL 
cholesterol. Addition of human or rat HDL to ACTH- 
stimulated rat adrenocortical cells results in a saturable, 
concentrationdependent enhancement of steroid hor- 
mone production (1 9). The increase in steroid hormone 
production greatly exceeds the amount of cholesterol 
released by cell-associated HDL protein degradation, 
suggesting that lysosomal degradation of the HDL par- 
ticle is not required for utilization of HDL cholesterol 
as steroidogenic substrate. Furthermore, Glass et al. (22) 
have shown that rat adrenal accumulation of HDL 
cholesterol ethers, a nondegradable analog of cholesteryl 
esters, greatly exceeds accumulation of HDL apoproteins 
covalently linked to nondegradable tyramine-cellobiose. 
Our preliminary studies (28) have shown that rat 
adrenocortical cells possess distinctive saturable recog- 
nition sites for high density lipoproteins. Christie, 
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Gwynne, and Strauss (29) and Strauss, MacGregor, and 
Gwynne (30) have demonstrated HDL binding sites in 
rat ovarian cells and have shown that binding is hor- 
monally regulated, while Chen, Kraemer, and Reaven 
(3 1) have reported that rat testes membranes bind HDL 
in a hormonally dependent fashion. The in vivo studies 
of Kovanen et al. (26) in the mouse likewise suggest 
that cellular uptake of HDL cholesterol may be mediated 
by a receptor distinct from that responsible for uptake 
of LDL cholesterol. In order to better understand the 
mechanism responsible for cellular uptake of HDL cho- 
lesterol, we have first sought to further characterize the 
interaction between HDL and rat adrenocortical cells. 
Our studies indicate that HDL receptor activity differs 
from the LDL receptor in specificity, kinetics, temper- 
ature dependence, effects of divalent cations, and sus- 
ceptibility to enzymatic attack. The kinetics of HDL 
binding suggest that only a small portion of bound HDL 
apoprotein becomes internalized. Moreover, internaliza- 
tion does not necessarily lead to HDL apoprotein deg- 
radation. 
METHODS 
Preparation and characteristics of lipoproteins 
Serum for preparation of human HDL3 (1.125 < d 
< 1.210 g/ml) and LDL (1.019 < d < 1.055 g/ml) was 
collected in EDTA (1 mg/ml) from normal fasting males 
and females. We have frequently used human as well as 
rat HDL in our studies since rat HDL contains large 
amounts of apoE (32), an apoprotein which mediates 
binding to the LDL receptor (33), while human HDL, 
particularly that of density greater than 1.085 g/ml, 
contains practically no apoE. Moreover, our earlier 
observations (28) have shown little difference in affinity 
between human and rat HDL. Thus, human HDL, 
while behaving similarly to rat HDL, can be prepared 
in a form which will not interact with the LDL receptor. 
The lipoproteins were separated by sequential density 
ultracentrifugation according to the method of Havel, 
Eder, and Bragdon (5). Centrifugation was performed 
for 24 hr at 4OC and 50,000 rpm in a Beckman 60 Ti 
centrifuge head, except at density 1.21 g/ml where 
centrifugation was continued for 48 hr. Lipoproteins 
were recovered by tube slicing and recentrifuged once 
for 24 hr at the upper density limit. Purified lipoproteins 
gave a single band on agarose electrophoresis (34), and 
were free of contaminating lipoproteins and serum 
albumin as judged by Ochterlony immunodiffusion. To 
assess purity and further characterize the isolated lipo- 
proteins, a qualitative estimation of apoprotein comple- 
ment was obtained by polyacrylamide slab gel electro- 
phoresis (40 to 100 p protein per lane) in 0.1% SDS 
according to Rudolph and Krueger (35). By these tech- 
niques human HDL was free of apoB and apoE while 
human LDL was free of HDL apoproteins. The apoE 
content of three different preparations of HDL used in 
these experiments, kindly determined by radioimmu- 
noassay by Dr. Conrad Blum, was less than 0.3% of the 
protein by weight. Assuming a molecular weight of 
110,000 for total HDL apoprotein and 33,000 for apoE 
(6), less than 1% of the HDL particles would be expected 
to possess apoE. Moreover, HDL used in these studies 
was ineffective at concentrations of up to 300 pg of 
protein/ml in enhancing steroid production by cultured 
mouse Y-1 adrenal cells which accumulate steroidogenic 
substrate cholesterol by LDL receptor-mediated endo- 
cytosis (1 3). The mean ratios of cholesterol to protein 
for human HDL and human LDL were 0.5 and 2.3, 
respectively. HDL was iodinated as previously described 
(28). Iodinated lipoproteins were dialyzed immediately 
prior to use. 
Preparation and characteristics of cell suspension 
and primary cultures 
Untreated retired female breeder Sprague-Dawley 
rats (Zivic-Miller) (250-350 g), maintained in a light- 
controlled environment and fed standard laboratory 
chow, were killed by pentobarbital (30 mg i.p.) between 
8:OO and 9:00 AM, at the beginning of the 12-hr light 
period. Primary suspensions of adrenocortical cells were 
prepared from decapsulated glands using collagenase, 
hyaulronidase digestion, and mechanical dissociation as 
previously described (1 9). Where indicated, cells were 
also prepared in a similar fashion without additional 
difficulty from rats injected intraperitoneally daily for 3 
days with 4-aminopyrazolopyrimidine (4-APP) (2 mg/ 
100 g body weight) (19). Freshly prepared cells were 
suspended in lipoprotein-poor media A (Gibco MEM 
#320-2570, 10% lipoprotein-poor fetal calf serum, 1% 
penicillin-streptomycin) and used immediately, or in 
complete media B (MEM, 10% fetal calf serum, 1% 
penicillin-streptomycin) and plated in sterile plastic cul- 
ture dishes (Falcon #3002) in the absence of ACTH. 
Analytical methods 
Lipoprotein binding was determined by incubating 
fresh cell suspensions with '251-labeled HDL at 37OC in 
a shaking water bath (approximately 12 cycles/min). 
Under these conditions cells remained intact, viable, 
and responsive to ACTH as shown by their ability to 
maintain linear rates of steroid output for up to 8 hr. 
Bound and free '251-labeled HDL were separated by 
centrifugation of 200-pl aliquots of the incubation mix- 
ture for 2 min in a Beckman #152 microfuge over a 
2 0 0 4  layer of phosphate-buffered saline (pH 7.4). The 
supernatant was aspirated and the tip of the centrifuge 
tube containing the cell pellet was cut from the tube 
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and counted in a Beckman Model 300 gamma counter 
with an efficiency of approximately 70%. These condi- 
tions were chosen on the basis of preliminary experiments 
that indicated that cell pelleting was complete by 2 min, 
but that contamination of the tip of the centrifuge tube 
by diffusion of unbound '2sI-labeled HDL was virtually 
absent. Unless otherwise indicated, specific binding, the 
difference between the amount bound in the presence 
and absence of excess unlabeled lipoprotein, is reported. 
Similarly, we have used the expression "nonspecific" 
binding to indicate tissue accumulation of tracer which 
is not prevented by concurrent exposure to excess 
unlabeled ligand. 
Protein was measured by the method of Lowry et al. 
(3.6). DNA was measured using mithramycin by the 
fluorescent technique of Hill and Whatley (37). The 
statistical significance of differences in the mean was 
determined using Student's t-test. Unless otherwise in- 
dicated, lipoprotein concentrations are reported as li- 
poprotein protein per unit volume. 
Materials 
Carrier-free ln51 was obtained from Amersham Corp., 
Arlington Heights, IL and 4-APP was from Aldrich, 
Milwaukee, WI. Goat anti-human albumin and anti- 
human LDL were obtained from Antibodies Inc., Davis, 
CA and rabbit anti-human HDL was from Behring 
Diagnostics, Summerville, NJ. All other materials were 
reagent grade or better. 
RESULTS 
Binding in vivo 
Experiments were performed to determine if saturable 
binding of human HDL previously observed in vitro 
(28) also occurs in vivo. Rats, pretreated with 4-APP to 
lower circulating lipoprotein concentration were anes- 
thetized with pentobarbital, and the femoral vein was 
cannulated. Human '251-labeled HDL in 0.15 M NaCl 
alone or with a 10-fold excess of unlabeled HDL was 
infused continuously for 25 min. Two hours after the 
start of the infusion the animals were killed with pen- 
tobarbital (40 mg i.p.) and the vascular bed was perfused 
via the left ventricle with 50 ml of normal saline. The 
adrenals, ovaries, and fragments of other organs were 
excised, blotted, weighed, and counted. The adrenals 
and ovaries from rats perfused both with and without 
unlabeled HDL bound more '2sI-labeled HDL than did 
nonsteroid-producing tissues such as kidney, heart, and 
adipose tissue (Fig. 1). Moreover, the amount of 1251- 
labeled HDL associated with the adrenal was significantly 
reduced by concurrent administration of unlabeled HDL 
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Fig. 1. In vivo binding of '451-labeled HDL. Adult Sprague-Dawley 
rats (250-300 g) treated with 4-APP (2 mg/100 g i.p. daily for 3 
days) were anesthetized with pentobarbital (30 mg i.p.) and the 
femoral vein was cannulated prior to infusion of human 'P51-labeled 
HDL (0.15 mg, 133 cpm/ng) in 0.5 ml of normal saline alone (no 
HDL) or with unlabeled HDL (1.5 mg). Infusion was continued for 
25 min. Ninety-five min later, the animals were killed, the inferior 
vena cava was incised, and the carcass was perfused through the left 
ventricle with 50 ml of normal saline. The organs were excised, 
trimmed, blotted, weighed, and counted. The amount of bound '"I- 
labeled HDL was related to the tissue net weight. The mean and 
range of duplicate determinations of duplicate infusions are shown. 
(Student's t test; P < 0.05) suggesting that the rat adrenal 
cortex binds HDL in vivo in a saturable fashion similar 
to that previously observed in vitro (28). Similar findings 
have been reported by Andersen and Dietschy (20) in 
the rat and Kovanen et al. (26) in the mouse. Concurrent 
administration of unlabeled HDL also decreased ovarian 
binding. The association of large amounts of '251-labeled 
HDL with the ovary is consistent with the studies of 
Strauss, MacGregor, and Gwynne (30) who have reported 
the presence of specific HDL binding sites in luteinized 
rat ovaries. Although of essential importance, in vivo 
studies such as these require large quantities of lipopro- 
teins, they may be subject to ambiguous interpretation 
because of uncontrolled hormonal and metabolic factors, 
and they are difficult to quantitate because circulating 
lipoproteins undergo intravascular modifications (6, 7). 
T o  better understand the properties and function of 
the adrenal HDL receptor, we have therefore used 
isolated adrenocortical cells. 
Specific '251-labeled HDL binding increases linearly 
with increasing cell concentration. When freshly isolated 
cell suspensions prepared from untreated rats at the end 
of the dark period were incubated with '251-labeled 
HDL (1 4 pg/ml) for 20 min in the presence and absence 
of unlabeled HDL (540 pg/ml), the amount of lZ5I- 
labeled HDL specifically bound increased linearly with 
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increasing cell concentration up to the maximum con- 
centration examined, 2.0 X lo6 cells per ml. Subsequent 
studies have employed cells suspended at a concentration 
of between 1.0 and 2.0 X lo6 cells/ml. At this cell 
density and using concentrations of human '251-labeled 
HDL from 5 to 15 pg/ml, conditions frequently em- 
ployed in this study, up to 9% of the added 1251-labeled 
HDL is specifically bound. 
To determine the time course of association, fresh 
suspensions of rat adrenocortical cells were incubated at 
37OC with human 1251-labeled HDL for 5 hr in the 
presence and absence of excess unlabeled HDL (Fig. 2). 
At regular intervals, free and cell-associated 1251-labeled 
HDL were separated by centrifugation. In agreement 
with our preliminary observations (28), the amount of 
cell-associated lS5I increased rapidly during the first 60 
min of incubation but much more slowly thereafter. 
The time at which maximum accumulation of IZ5I 
occurred varied greatly among experiments. In twelve 
different preparations of fresh adrenal cell suspensions, 
maximum accumulation had occurred by 3 hr in five, 
and by 8 hr in three. In the remaining four experiments 
a plateau value had not been reached when the experi- 
ment was terminated between 4 and 5 hr. 
1 ADDITION OF UNLABELED HDL 
I 
The slow cellular accumulation of '''I beyond 60 
min could not be attributed to "nonspecific" adsorption 
inasmuch as concurrent addition of excess unlabeled 
HDL prevented both the initial (0 to 60 min) rapid and 
second (beyond 60 min) slower process of association. 
Moreover, binding was performed in the presence of 
10% lipoprotein-poor fetal calf serum indicating that 
nonlipoprotein serum proteins do not compete with 
HDL for receptor site occupancy. T o  determine if 
exchange of labeled lipids could account for the increas- 
ing accumulation beyond 60 min, cells incubated with 
'251-labeled HDL for 90 and 180 min were recovered 
by centrifugation and the counts extractable with chlo- 
roform-methanol 2: 1 were determined. In one typical 
experiment, the total number of cell-associated counts 
increased 11% during this interval. At 90 min, 6.1% of 
the total counts were extractable. This increased slightly 
to 9.0% at 180 min. This exchange of labeled lipid 
accounted for less than 30% of the total increase while 
"nonspecific" binding accounted for less than 16%. 
Thus, greater than 50% of the increase could be attrib- 
uted to specific cellular uptake of iodinated protein. 
The rate of cell accumulation of lZ5I from 60 to 180 
min could be approximated as a linear function of time. 
In five experiments in which cells prepared from un- 
treated rats were incubated with human 1251-labeled 
HDL (5-10 pg/ml), the mean rate of association was 
1.13 k 0.5 1 ng of 1251-labeled HDL mg of cell protein 
per minute (range 0.68 to 1.91). The mean correlation 
coefficient was 0.95, indicating that over this time period 
accumulation was indeed linear with time. When the 
rate of accumulation beyond 60 min was extrapolated 
to zero time and subtracted from total cell accumulation, 
the resulting accumulation plateaued in less than 60 
min. The rate constant, for rapid accumulation, was 
20.1 & 5.5 minutes. As will be shown below, this is in 
remarkable agreement with the rate constant for accu- 
mulation of reversibly bound material. 
We next sought to determine if binding was reversible. 
Addition of excess unlabeled HDL to cells preincubated 
for 120 min with human '251-labeled HDL resulted in 
rapid dissociation (Fig. 2, 0) of only a portion of the 
cell-associated lZ5I. The remainder was released much 
more Slowly. The initial rate of dissociation was to0 
rapid to determine using current techniques but ap- 
peared by 5 min. Dissociation occurred with 
rapidity and to the Same extent when labeled 
ligand was dissociated in the absence of added excess 
the labeled 
ligand$ in the absence Of HDL* 
pre-incubated with '251-labeled HDL were recovered by 
centrifugation and resuspended in ten times their initial 
sociation curves observed in the presence and absence 
too 200 300 
TIME (Minutes) 
Fig. 4. Rates of association and dissociation of '"1-labeled HDL 
with suspension and rat adrenocortical cells. Fresh suspensions of 
adrenocortical cells (1.8 X 106 cells/ml in 9 ml) of media A prepared 
from glands excised from adult male Sprague-Dawley rats were 
incubated with '*'I-labeled HDL (1 pg/ml, sp act 340 cpm/ng) in 
the presence (0) or absence (0) of excess unlabeled HDL (650 rg/ 
ml). At 2 hr, excess unlabeled HDL (100 rg/ml) was added to 6 ml 
of the cell suspension previously incubated with '5'1-labeled HDL 
alone (0). Cells from a second 6-ml aliquot were recovered by 
centrifugation (1 100 g for 6 min) and resuspended in ten times the 
initial volume (A). The amount of 'Psl-labeled HDL bound was 
determined by counting the cell pellets recovered by centrifugation 
of duplicate 200-pl aliquots of duplicate incubations and related to 
cell protein. The range of determinations was always less than 10% 
of the mean. 
HDL ( ~ i ~ ,  2, A). T~ 
Of lipoprotein free media- The coincident 
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of excess unlabeled HDL indicate that receptor coop 
erativity (38) does not account for the observed disso- 
ciation kinetics. 
The amount of cell-associated 1251 that could be 
rapidly released by addition of unlabeled HDL was next 
determined as a function of time. At various intervals, 
up to 2 hr, excess unlabeled HDL was added to suspen- 
sions of rat adrenocortical cells preincubated with lZ5I- 
labeled HDL in the absence of unlabeled HDL (Fig. 3). 
The incubation was continued for 10 min to allow 
complete release of the dissociable material and free 
and bound '251-labeled HDL were separated by centrif- 
ugation. Control incubations in the presence of unlabeled 
HDL were also performed. The total amount of cell- 
associated material and the amount remaining cell- 
associated 10 min after addition of unlabeled HDL are 
shown in curve A and curve B, respectively (Fig. 3). 
The amount of reversibly bound material, the difference 
between total and nondisplaceably bound '251-labeled 
HDL (dotted line, Fig. 3) increased rapidly until a 
plateau value was reached at approximately 60 min. In 
contrast, the material that was not rapidly dissociable 
increased much more slowly but continued to increase 
well beyond 60 min. Qualitatively identical results were 
obtained when fresh suspensions of rat adrenocortical 
cells were incubated with iodinated rat HDL (data not 
shown). However, the amount of displaceable rat HDL 
MINUTES 
Fig. 3. Reversibly and nonreversibly bound 1P51-labeled HDL as a 
function of time. Fresh suspensions of adrenocortical cells (1.22 
X lo6 cells/ml) prepared from adult female Sprague-Dawley rats 
were incubated with '*'I-labeled HDL (1.1 pg/ml, 89 cpm/ng) in 
the absence (curve A) and presence (curve D) of excess unlabeled 
HDL (500 pg/ml). At the indicated times, duplicate aliquots (0.2 
ml) were removed and bound 1251-labeled HDL was determined. In 
addition, duplicate aliquots (0.2 ml) were added to 0.2 ml of HDL 
( 1  mg/ml), incubated for 5 min at 37'C. and bound 1P51-labeled 
HDL was determined (curve B). Curve C was calculated as the 
difference between curves A and B. 
accumulated by the cells reached a maximum in less 
than 30 min, rather than 60 min as with human HDL. 
One phenomenon that could account for the observed 
cellular accumulation of nondisplaceable '251-labeled 
HDL is endocytosis of surface bound material. T o  
explore this possibility, binding by broken cell prepara- 
tion was examined (Fig. 4). Rat adrenal glands were 
excised, trimmed, decapsulated, and homogenized by 
ten strokes of a loose-fitting sintered glass homogenizer. 
Nuclei and unbroken cells were removed by low speed 
centrifugation (800 g, 10 min). A partially purified 
membrane fraction also containing numerous intracel- 
lular organelles was derived from the supernatant by 
subsequent centrifugation (1 0,500 g, 20 min). The pel- 
leted material was resuspended (1 30 pg of protein/ml) 
and incubated with '251-labeled HDL (4 pg/ml) in the 
presence and absence of a 100-fold excess of unlabeled 
HDL. Bound and free '251-labeled HDL were separated 
by centrifugation. At regular intervals total binding was 
determined and excess unlabeled HDL was added to 
incubation not previously exposed to unlabeled HDL. 
The rate of decrease in bound '251-labeled HDL follow- 
ing addition of unlabeled HDL was also followed with 
time (Fig. 4). As with intact cells, addition of excess 
unlabeled HDL to cell homogenates preincubated with 
'"I-labeled HDL resulted in rapid displacement of only 
a portion of the specifically bound material. The re- 
maining bound iodinated material was released much 
more slowly. Thus, cell integrity is not required for 
accumulation of nondissociable '251-labeled HDL, sug- 
gesting that the nondissociable material has not been 
internalized. 
To determine if lysosomal processing is responsible 
for nondissociable cell accumulation of 'z51-labeled HDL, 
the effects of chloroquine on cellular accumulation of 
'251-labeled HDL were examined. In the case of LDL 
(8, 12) a portion of the internalized lipoprotein particles 
undergoes lysosomal degradation. Inhibition of lysosomal 
hydrolysis by chloroquine in cultured human fibroblasts 
leads to decreased LDL degradation and enhanced 
cellular accumulation. Although our previous studies 
have shown that lysosomal degradation of HDL is not 
necessary for utilization of HDL cholesterol as steroido- 
genesis substrate, they do not exclude the occurrence 
of internalization and lysosomal degradation of HDL. 
Iodinated human HDL was therefore incubated with 
primary cultures of rat adrenal cells in the presence and 
absence of varying concentrations of chloroquine, an 
inhibitor of lysosomal hydrolysis (Fig. 5). Addition of 
chloroquine produced a dose-dependent inhibition of 
steroidogenesis, but had no effect on 1251-labeled HDL 
degradation. Moreover, addition of chloroquine did not 
enhance cellular accumulation of iodinated HDL at any 
dose up to 500 pg/ml (data not shown). In three other 
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Fig. 4. Time course of binding and dissociation of 'PbI-labeled HDL 
to partially purified rat adrenal plasma membranes. Crude plasma 
membrane suspensions prepared by differential centrifugation from 
homogenates (six strokes of a loose-fitting sintered glass homogenizer) 
of decapsulated adrenal glands excised from untreated adult female 
Sprague-Dawley rats (130 fig protein/ml) were incubated in MEM 
plus 10% lipoprotein-poor fetal calf serum with human 1P51-labeled 
HDL (4 rg/ml; sp act 257 cpm/ng) in the absence (0) and presence 
(A) of unlabeled HDL (500 pg/ml). At the indicated times, triplicate 
0.2-ml aliquots were removed from duplicate incubations and bound 
1P51-labeled HDL was separated by centrifugation. In addition, at 5, 
10, 15, and 30 min following addition of unlabeled HDL (500 Pg/ 
ml), bound 'P51-labeled HDL was measured after centrifugation of 
duplicate 0.2-ml aliquots. 
experiments of up to 5 hr duration, mean total cellular 
accumulation of '251-labeled HDL was no different in 
the presence than in the absence of chloroquine (50- 
100 PM). To be sure that the apoproteins of HDL could 
undergo lysosomal proteolysis, we examined the degra- 
dation of '251-labeled HDL by adrenal homogenates at 
acid pH (Fig. 6). Maximum degradation occurred at pH 
4.5 and was more than 10 times greater than that 
occurring at pH 7.4. The HDL apoproteins do not 
therefore appear resistant to lysosomal degradation. 
Inhibition of lysosomal function does not lead either to 
inhibition of HDL degradation or to enhanced cellular 
accumulation of HDL. Thus, if endocytosis of HDL 
occurs, it is not necessarily coupled to lysosomal apopro- 
tein degradation. Additional studies are underway to 
determine the subcellular location of the nonreversibly 
bound iodinated material. 
To characterize the apoprotein complement of the 
reversibly and nonreversibly bound iodinated material, 
fresh cell suspensions were preincubated with human 
'251-labeled HDL (5 Pg/ml) for 4.5 hr and recovered 
by sedimentation. The reversibly bound material was 
released from resuspended cells by incubation with a 
one hundred-fold excess unlabeled HDL for 10 min. 
The released iodinated material and that bound to the 
cells were solubilized by SDS (2%). The apoprotein 
composition was analyzed by polyacrylamide gel electro- 
phoresis and compared to unincubated HDL and media. 
Each sample exhibited only three bands which comi- 
grated with apoA-I, apoA-11, and C-peptides. No higher 
nor lower molecular weight bands were observed. It 
should be noted that apoE-containing material could 
not be identified by this technique in any of these 
fractions. 
Our preliminary studies (28) have shown that cellular 
accumulation of human and rat lP51-labeled HDL occurs 
by a saturable process since addition of excess unlabeled 
lipoprotein prevents accumulation of labeled material. 
In order to determine the affinity and number of 
putative binding sites, fresh suspensions of adrenal cells 
obtained at the beginning of the light cycle from un- 
treated rats were incubated for 40-60 min with increas- 
ing amounts of human '251-labeled HDL in the presence 
and absence of excess unlabeled HDL (1.05 mg/ml). 
The duration of incubation was chosen to allow near 
completion of the reversible phase of cell accumulation 
while minimizing the contribution of the nonreversibly 
bound counts. Results typical of five such experiments 
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Fig. 5. Effects of chloroquine and steroidogenesis and 'z51-labeled 
HDL degradation. Fresh suspensions of rat adrenocortical cells were 
prepared from decapsulated glands excised from adult female Sprague- 
Dawley rats treated for 3 days with 4-APP (4 mg i.p.) and incubated 
for 20 hr with 1451-labeled HDL (24 fig/ml; sp act 122 cpm/ng) in 
the presence and absence of unlabeled HDL (260 rg) and various 
concentrations of chloroquine. Bound and free '451-labeled HDL 
were separated by Centrifugation and specific binding was determined 
as the difference between binding in the presence and absence of 
unlabeled HDL. Specific degradation was determined as the difference 
between the number of counts remaining in solution after TCA 
treatment (SO min. 4'C) and centrifugation of media obtained from 
incubation with and without cells. 
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Fig. 6. Degradation of 1z51-labeled HDL by rat adrenal homogenate 
at acid pH. Adrenal glands were excised from adult female Sprague- 
Dawley rats, trimmed, and suspended in either 0.05 M sodium 
phosphate (pH 6.5 and 7.5) or 0.05 M sodium acetate, and homog- 
enized for 10 sec with a Polytron. The pH was adjusted by addition 
of concentrated acid or base and 1P51-labeled HDL (10 rg/ml. sp act 
200 cpm/ng) was added. Following incubation (90 min, 37’C), the 
particulate material was removed by centrifugation (1 0.000 g, 10 
min); the supernatant was treated with TCA (lo%, 30 min, 4OC) 
after addition of bovine serum albumin (final concentration 0.5%). 
The amount of ‘g51-labeled HDL degraded was determined by 
dividing the number of soluble counts, after removal of the TCA- 
precipitable material by centrifugation (10,000 g, 20 min), by the 
specific activity of added 1P51-labeled HDL. 
are shown in Fig. 7. “Nonspecific” binding increased 
linearly with increasing lipoprotein concentration over 
the entire range examined. When the specifically bound 
‘251-labeled HDL, which under these conditions is greater 
than 90% reversibly bound, was determined as the 
difference between total and nonspecific binding, it had 
failed to plateau even at concentrations as high as 200 
pg protein/ml. These data were analyzed graphically 
using double reciprocals (Lineweaver-Burk) (Fig. 8A) 
and according to Scatchard (Fig. 8B). When fitted to a 
single straight line, the mean (n = 6) affinity constant 
derived from double reciprocal analysis was (& = 37 
k 12 pg/ml), (mean correlation coefficient = 0.98) and 
from Scatchard analysis were (& = 56 k 16 pg/ml), 
(mean correlation coefficient = -0.91). The number of 
sites per cell was 5.63 & 4.1 X IO5 and 7.45 2 5.2 
X lo5, respectively. Klotz (39) has recently pointed out 
the tendency of Scatchard analysis to underestimate 
binding capacity if insufficiently high ligand concentra- 
tions are examined. Thus, the estimates of binding 
capacity should be considered as minimal estimates. 
Moreover, subsequent studies have shown that the num- 
ber of binding sites is regulated by ACTH. 
The number and affinity of lipoprotein binding sites 
were also determined by incubating cell suspensions 
with a fixed amount of iodinated HDL in the presence 
of increasing concentrations of unlabeled HDL (Fig. 
9A) (29, 30). At each concentration of added unlabeled 
material, a new specific activity was calculated and the 
amount of total cell-associated material was determined 
from total cell-associated counts and the revised specific 
activity (Fig. 9B). These results are typical of four such 
experiments. This type of “competitive binding” exper- 
iment is technically much easier to perform, since it 
facilitates measurement of binding at high lipoprotein 
concentrations and requires fewer cells. The results of 
these studies using a fixed amount of labeled material 
were identical to those obtained using increasing amounts 
of iodinated HDL. The data were analyzed graphically 
using double reciprocals (Kd = 27 f 23 pg/ml, N 
= 3.2 f 2.0 X lo6 sites/cell) or Scatchard (& = 47 
f 40 pg/ml, N = 1.01 f 1.02 X 1 O6 sites/cell) employing 
a one-site model. Similar studies have been performed 
using rat HDL. 
To determine if the putative HDL receptor has 
properties similar to those of the LDL receptor of 
cultured fibroblasts and bovine adrenocortical cells, we 
examined the effect of temperature, calcium, and pro- 
tease treatment on HDL binding. When cell suspensions 
20 40 60 00 100 
CONCENTRATION 1251-HDL3 ( y g  proteinlml ) 
Fig. 7. Concentration dependence of total and nonspecific I z 5 1 -  
labeled HDL binding. Fresh suspensions of rat adrenal cells (23 pg 
DNA/ml) from decapsulated glands excised from adult female 
Sprague-Dawley rats were incubated (40 min, 37OC) with increasing 
concentrations of ’PbI-labeled HDL (sp act 90 cpm/ng) in the 
presence (0) and a k n c e  (0) of unlabeled HDL (1.05 mg/ml). 
Bound and free ’P51-labeled HDL were separated by centrifugation. 
Specific binding (- - -) was calculated as the difference between total 
and nonspecific binding. 
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Graphical analysis of  data in Fig. 7 by A, double reciprosals Fig. 8. 
(cc = 0.98) and 9, Scatchard analysis (cc = -0.80). 
were incubated with '251-labeled HDL at 37"C, 25"C, 
and 4°C (Fig. lo), the amount of '251-labeled HDL 
accumulated by the cells decreased with decreasing 
temperature at all times examined. The decline is due 
not only to a decreased rate of association but also to a 
decreased number of interactions since binding at 4" 
and 25" plateaus much lower than at 37°C. Both the 
rapid and slow processes of accumulation were inhibited. 
In order to determine if dissociation could be retarded 
at low temperatures, cells (3.3 x io5 cells/ml) were 
preincubated at 37°C with 1251-labeled HDL (20 pg/ 
ml) for 2 hr and then transferred to 4°C. After 5 min 
at 4"C, excess unlabeled HDL (290 pg/ml) was added. 
Cells transferred to 4°C but not receiving unlabeled 
HDL and cells maintained at 37" with and without 
added unlabeled HDL served as controls. The rates of 
dissociation following addition of unlabeled HDL at 
37°C and 4°C were identical. No dissociation occurred 
from control cells maintained in the presence of lZ5I- 
labeled HDL without addition of unlabeled HDL either 
at 4" or 37°C. 
To determine if calcium is required for binding of 
HDL, cells (2.4 X 106/ml in phosphate-buffered saline, 
pH 7.4, plus 0.5% bovine serum albumin) were incubated 
with '251-labeled HDL in the presence and absence of 
EDTA (1 mM). Cells incubated with EDTA bound much 
more (1 47 ng/mg cell protein) than did cells incubated 
in the absence of EDTA (96 ng/mg cell protein). That 
added EDTA effectively chelated available calcium was 
confirmed by abolition of ACTH-stimulated steroido- 
genesis in control cell incubations (40). Addition of 
calcium at concentrations up to 10 mM in the absence 
of EDTA to cells (2.5 X lo6 cells/ml in MEM plus 10% 
lipoprotein-poor human serum) incubated with '''I- 
labeled HDL (0.5 &ml) had no effect on accumulation. 
Finally, we have examined the effects of cell exposure 
to trypsin or pronase on the ability of cells to bind 
HDL. Suspensions of adrenocortical cells freshly pre- 
pared from 4-APP-treated rats were preincubated in 
I I 1 I I 
I 2 3 4 5 - CONCENTRATION UNLABELED (Ag/ml) x 
TOTAL HDL CONCENTRATION (hg/ml x 10-2) 
Fig. 9. Effects of increasing unlabeled HDL on binding of  Iy5I- 
labeled HDL by rat adrenal cells. A, Fresh suspensions of rat adrenal 
cells (0.47 X lo6 cells/ml) prepared from glands excised from adult 
female Sprague-Dawley rats pretreated for 3 days with 4-APP (2 
mg/100 g, i.p.) were incubated (2 hr, 37°C) with 1P51-labeled HDL 
(5.4 pg/ml, sp act 209 cpm/ng) in the presence of increasing 
concentrations of unlabeled HDL. Bound and free 1*511-labeled HDL 
were separated by centrifugation. 9, Total bound HDL was calculated 
from the data in A according to the text after subtracting nonspecif- 
ically bound HDL determined as the amount bound in the presence 
of a 100-fold excess of unlabeled HDL. 
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Fig. 10. Effects of temperature on time course of 'P51-labeled HDL 
binding. Duplicate suspensions of fresh adrenal cells prepared from 
adult female Sprague-Dawley rats were incubated with 'S511-labeled 
HDL (10 pg/ml. sp act 255 cpm/ng) in the presence and absence 
of a 15-fold excess of unlabeled HDL at the temperature indicated. 
At regular intervals, duplicate 0.2-ml aliquots were removed and 
bound and free 'P51-labeled HDL was separated by centrifugation. 
the presence and absence of trypsin (2.5 mg/ml) or 
pronase (2 pg/ml) for 1 hr at 37°C. In each case, 
treated and control cells were recovered by centrifuga- 
tion, washed once with Eagle's minimum media (MEM), 
resuspended in MEM plus 10% lipoprotein-poor fetal 
calf serum, and incubated (30-90 min, 37OC) with "'1- 
labeled HDL (0.7 to 10 pg/ml) in the presence and 
absence of at least a IO-fold excess of unlabeled HDL. 
T o  insure that the digestive enzymes were active, the 
amount of TCA-soluble ln51 produced by incubating 
'P51-labeled HDL with enzyme in the absence of cells 
was determined. In four separate experiments employing 
several different concentrations of ln5I-labeled HDL and 
durations of incubation, no difference in the amount of 
1z51-labeled HDL specifically bound could be detected 
between cells preincubated with and without either 
degradative enzyme. 
DISCUSSION 
The first objective of these studies was to determine 
if saturable cellular uptake of 1z51-labeled HDL previously 
observed in vitro also occurs in vivo. After pretreating 
the animals with 4-APP to lower endogenous lipoprotein 
levels, the ovary and adrenal were found to accumulate 
much more '251-labeled HDL than any other tissues 
examined, suggesting that HDL may perform a unique 
specific function in these tissues. Concurrent administra- 
tion of unlabeled HDL significantly reduced adrenal 
'251-labeled HDL accumulation. Thus in vivo accumu- 
lation like uptake in vitro is saturable. Similar findings 
have been reported by Andersen and Dietschy (20, 21) 
and Glass et al. (22, 41) in the rat, and Kovanen et al. 
in the mouse (26). Our findings in the ovary support 
the earlier findings of Strauss and colleagues (29, 30) 
which also suggest that in vivo accumulation of "'I- 
labeled HDL is saturable. The failure of specific ovarian 
uptake to reach statistical significance in this study may 
be due to the small number of observations and the 
uncertain state of gonadotropin stimulation in older 
female rats. 
Since intravascular lipoprotein modification makes 
interpretation of in vivo lipoprotein action difficult, we 
subsequently examined HDL binding by isolated cells. 
All binding studies were performed in a range of cell 
concentrations where HDL binding was linearly related 
to cell number. Because of the relative low affinity of 
the HDL interaction and the difficulty in obtaining large 
numbers of rat adrenal cells, most binding studies were 
performed under conditions where only 1-3% of the 
added labeled HDL was bound. At higher cell concen- 
trations, as much as 9% of the added labeled HDL was 
specifically bound. This precludes apoE as the sole 
determinant for receptor recognition since it comprised 
less than 0.3% by weight of the added HDL apoprotein. 
Moreover, cyclohexanedione modification, previously 
shown to block apoE-mediated binding to the LDL 
receptor (42), does not alter HDL binding to the adrenal 
(Gwynne, J. T., T. Hughes, and B. Hess, unpublished 
The kinetics of association and dissociation in vitro 
suggest that adrenal uptake of '251-labeled HDL is 
comprised of at least two events. One event is reversible 
binding to a saturable number of sites. A portion of the 
cell-associated '251-labeled HDL can be rapidly dissociated 
either by addition of excess unlabeled HDL or by 
lowering the concentration of unbound ligand. When 
characterized by SDS-PAGE, the reversibly bound ma- 
terial exhibits the same distribution of Iz5I among apo- 
proteins as unincubated HDL. Thus the reversibly bound 
species is not a subpopulation.of added ligand selected 
on the basis of apoprotein complement. Moreover, no 
modification in the complement of apoprotein results 
from reversible binding. Reversible binding progressed 
rapidly and reached a maximum by 60 min. Our previous 
studies have shown that addition of HDL to cholesterol- 
depleted rat adrenocortical cells in the presence of 
ACTH causes a progressive increase in the rate of 
steroidogenesis for the first 60 min. After the first 60 
min the maximal rate of enhanced steroidogenesis is 
data). 
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achieved (1 9). Thus, as the amount of reversibly bound 
'251-labeled HDL increases, so does the rate of steroido- 
genesis, suggesting that reversible HDL binding is at 
least initially responsible for increased delivery of ste- 
roidogenic substrate cholesterol. 
Our results indicate that the second event resulting 
in cellular uptake of '251-labeled HDL is characterized 
by loss of reversibility, since neither addition of excess 
unlabeled material nor thorough washing releases lZ5I 
accumulated by this process. This second event begins 
immediately upon addition of I-labeled initially. It 
progresses more rapidly and subsequently continues 
more slowly, but at nearly a linear rate well beyond 3 
hr. This slow irreversible accumulation of 1251 results 
from a limited number of interactions since addition of 
excess unlabeled HDL blocks this phenomenon. More- 
over the slow and protracted rate of irreversible associ- 
ation suggests that it is not due to adsorption alone, 
since adsorption is diffusion-controlled and rapidly com- 
plete. The process of adsorption may exhibit character- 
istics identical to those of receptor binding (43). Ad- 
sorption is generally characterized by interactions at a 
large number of low affinity sites. Adsorption of some 
radiolabeled ligands, such as insulin (44) and LDL (45), 
to nonphysiologic surfaces, such as talc or glass, may 
exhibit properties including affinity and ligand specificity 
identical to those which characterize physiologically 
meaningful interactions. Such nonphysiologic surfaces 
may possess properties such as charge which are similar 
to the physiologic receptor. Thus the demonstration of 
a true receptor requires that binding be related to a 
physiologic response. In the case of rat adrenocortical 
cells, HDL binding is associated with enhanced steroido- 
genesis, although the mechanisms linking binding and 
cholesterol uptake are unknown. In contrast, human or 
rat 1251-labeled HDL does not associate either reversibly 
or irreversibly to human or rat red blood cells (data not 
shown). 
The properties of HDL responsible for receptor 
recognition and, therefore, the receptor specificity re- 
main unknown. Our preliminary results (28) have shown 
partial competition of LDL for '251-labeled HDL binding, 
suggesting that either apoB and apoA-I share common 
determinants or a nonprotein; perhaps a glycolipid 
constituent found in both LDL and HDL determines 
binding. These possibilities are currently under investi- 
gation in our laboratory. Both reversible and irreversible 
accumulation of '251-labeled HDL exhibits specificity for 
lipoproteins since our studies were performed in the 
presence of 10% lipoprotein-poor fetal calf serum which 
did not block HDL binding. 
Several mechanisms that could explain the loss of 
reversibility were examined. First, the increase in lipid 
extractable counts was directly measured and could not 
account for the increase. Second, the lack of high 
molecular weight bands on SDS-PAGE indicates that 
covalent association of the HDL apoprotein with a 
cellular constituent, such as has been reported for insulin 
(46), is not occurring. Third, loss of reversibility does 
not appear due to lysosomal accumulation since chloro- 
quine inhibition of lysosomal degradation does not en- 
hance accumulation. Moreover, it seems unlikely that 
irreversible association can be attributed to sequestration 
at any intracellular site since it progresses despite cell 
disruption. It should be noted that while our findings 
indicate secondary lysosome formation is not necessary 
for either enhanced steroidogenesis or irreversible 
apoHDL accumulation, they do not indicate that lyso- 
somal degradation of HDL does not occur since chlo- 
roquine may impede not only lysosomal function but 
also secondary lysosome formation (47). The ability of 
chloroquine to inhibit adrenal steroidogenesis has been 
previously observed (48) although the mechanism re- 
mains unknown. Chloroquine inhibition occurs even 
when intracellular cholesterol stores are the source of 
the steroidogenic substrate. Thus the mechanism of 
inhibition does not involve exclusively the lipoprotein 
pathways but probably some more general intracellular 
mechanism. 
At least three possible explanations for irreversible 
cell accumulation remain. Loss of reversibility in binding 
could result from i) incorporation of HDL apoproteins 
into the plasma membrane; ii) enhanced receptor affinity 
induced by binding; or iii) formation of membrane 
vesicles with apoprotein trapped within the interior. 
Several macromolecular ligands have been shown to be 
internalized by hepatocytes within membrane bound 
vesicles which do not form secondary lysosomes (49, 
50). The relationship of reversible binding to irreversible 
apoprotein accumulation is not known. Since reversible 
binding initially progresses more rapidly than irreversible 
accumulation, reversible binding may lead to irreversible 
uptake. Alternatively, reversible binding and irreversible 
accumulation could occur by interactions at distinct 
sites. 
The apparent affinity of the reversible receptor for 
HDL has been determined. Specific binding was mea- 
sured under pseudo-equilibrium conditions at 40 min, 
a time at which reversible binding is nearly complete 
but nonreversible binding is minimal. Binding ap- 
proached saturation at about 200 pg/ml. Two tech- 
niques, direct and competitive, were employed to mea- 
sure binding at varying HDL concentrations. Both tech- 
niques yielded similar results indicating that the tracer 
behaves the same as uniodinated HDL. When analyzed 
graphically, human HDL exhibited a Kd of 37 k 12 pg/ 
ml. This is in close agreement with the reported disso- 
ciation constants for HDL binding in other systems 
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including human '251-labeled HDL binding to isolated 
rat ovarian cells reported by Christie et al. (& = 19.8 
pg of protein/ml) (29); rat '451-labeled HDL binding to 
rat testicular membranes reported by Chen et al. (Kd 
= 32 pg of protein/ml) (31); human '251-labeled HDL 
binding to isolated rat hepatocytes (K, = 8.2 X lo6 M-I); 
approx. (& = 20 pg of protein/ml) and human IZ5I- 
labeled HDL binding to hepatic membranes (& = 10.5 
pg of protein/ml) reported by Ose et al. (51) and 
Chacko (52), respectively. 
These values are considerably less than the concen- 
tration of HDL required to achieve half-maximal en- 
hancement of steroidogenesis in the adrenal in vitro 
(19). Several possibilities could explain the discrepancy. 
First, cholesterol uptake may result not only from re- 
versible binding but also from the second irreversible 
event as well. The dependence of the latter event on 
HDL concentration is not yet known. Secondly, all 
receptor interactions might not result in cholesterol 
utilization for steroidogenesis. In fact, we have shown 
previously that cellular cholesterol accumulation occurs 
concurrently with HDL enhancement of steroidogenesis 
(19). The concurrent occurrence of these two events 
mediated by the same receptor would produce a right- 
ward shift of the dose-response curve for steroidogenesis 
compared to that for binding. 
Finally, we have compared the properties of the 
putative HDL binding sites to the properties of the LDL 
receptor and find that they differ not only in specificity 
and kinetics but in at least three additional ways as well. 
First, HDL binding does not require calcium. Second, 
maximal HDL binding decreases with decreasing tem- 
perature, although this may be due to temperature- 
induced changes in HDL structure rather than changes 
in temperature-induced changes in receptor activity. 
Third, the HDL receptor is not sensitive to trypsin 
digestion. 
In summary, the results of these studies further 
confirm that the interaction of HDL with steroidogenic 
tissues occurs by a mechanism distinct from the mecha- 
nism responsible for LDL uptake. The receptor differs 
in specificity, proteolytic sensitivity, and in the effects of 
temperature and calcium. Moreover, the kinetics of 
binding and dissociation also differ and, together with 
studies in broken cell preparation of the effects of 
lysosomatotropic agents, indicate that formation of a 
secondary lysosome is not essential for cellular utilization 
of HDL cholesterol. Moreover, many properties of 
adrenal HDL binding activity are exhibited by HDL 
binding activity in other tissues, suggesting that these 
receptors are similar if not identical. 
If HDL cholesterol is not released by secondary 
liposome formation, by what mechanism is HDL choles- 
terol made available for use as steroidogenic substrate? 
Three likely hypotheses are that endocytosis occurs and 
results either in I) changes in vesicle conditions causing 
release of HDLcholesterol analogous to the acid-induced 
release of iron from transferrin captured within hepatic 
endocytotic vessels (53) or 2) delivery of HDL to an 
intracellular organelle such as the GERL apparatus 
where lipoprotein dissembly could occur but would not 
result in apoprotein degradation. Such a process would 
be consistent with the known polarity of the GERL 
apparatus (54) and could be a reversal of the lipoprotein 
assembly mechanism (55). Finally, cholesterol could be 
taken by a specific enzyme or transport mediated process 
which would not require internalization of the lipoprotein 
particle but could account for the nonreversible phase 
of lipoprotein binding.l 
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